EYPT
EyePoint (EYPT)
NASDAQ
$14.64+$0.91 (+6.66%)
Price as of Jun 23, 2026 7:03 PM EDT
  • $1.2B
    Market Cap
  • 65.82%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
1.6M
-96.31%
43.3M
-5.97%
46.0M
+11.14%
41.4M
+12.09%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
1.6M
-96.31%
43.3M
-5.97%
46.0M
+11.14%
41.4M
+12.09%
Sales and Marketing Expense
90,000
-31.30%
131,000
-98.88%
11.7M
-54.17%
25.5M
-7.26%
Research and Development Expense
-221.0M
+66.29%
-132.9M
+105.57%
-64.7M
+30.26%
-49.6M
+74.18%
Depreciation and Amortization Expense
2.3M
+49.94%
1.5M
N/A
0
-100.00%
2.0M
-16.67%
Total Operating Expenses
274.8M
+45.30%
189.1M
+56.19%
121.1M
-14.15%
141.0M
+52.95%
Operating Profit
-243.4M
+66.90%
-145.9M
+94.30%
-75.1M
-24.66%
-99.6M
+80.25%
Interest Income
11.8M
-22.12%
15.1M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-1.2M
-60.90%
-3.2M
-42.00%
Interest Income and Expense and Net
11.8M
-22.12%
15.1M
+1,309.94%
-1.2M
-60.90%
-3.2M
-42.00%
Total Nonoperating Income and Expense
11.8M
-22.04%
15.1M
+246.13%
4.4M
+266.41%
-2.6M
-16.68%
Income before Taxes
-231.7M
+77.15%
-130.8M
+84.95%
-70.7M
-29.03%
-99.6M
+80.25%
Income Taxes
279,000
+210.00%
90,000
+8.43%
83,000
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
300,000
-75.00%
Net Income
-232.0M
+77.25%
-130.9M
+84.86%
-70.8M
-30.77%
-102.3M
+75.04%
Net Income from Continuing Operations Applicable to Common
-231.7M
+77.15%
-130.8M
+84.95%
-70.7M
-30.85%
-102.3M
+75.04%
Basic EPS and Net Income
-3.17
+36.64%
-2.32
+27.47%
-1.82
-33.58%
-2.74
+34.98%
Diluted EPS and Net Income
-3.17
+36.64%
-2.32
+27.47%
-1.82
-33.58%
-2.74
+34.98%
Basic Weighted Average Shares
73,251
+30.11%
56,298
-99.86%
38.9M
+4.25%
37.3M
+29.76%
Diluted Weighted Average Shares
73,251
+30.11%
56,298
-99.86%
38.9M
+4.25%
37.3M
+29.76%
Balance Sheet
Cash and Cash Equivalents
101.8M
+2.12%
99.7M
-64.55%
281.3M
+194.11%
95.6M
-46.45%
Short-Term Investments
204.3M
-24.68%
271.2M
+444.74%
49.8M
+1.76%
48.9M
+48.42%
Cash and Cash Equivalents and Short-Term Investments
306.1M
-17.48%
370.9M
+12.04%
331.1M
+129.00%
144.6M
-31.67%
Total Current Assets
328.7M
-14.26%
383.3M
+11.17%
344.8M
+99.53%
172.8M
-27.31%
Accumulated Depreciation
6.0M
+48.31%
4.1M
+57.80%
2.6M
+22.02%
2.1M
+67.75%
Property and Plant and Equipment and Net
9.0M
+10.35%
8.2M
+55.72%
5.3M
+286.10%
1.4M
+185.71%
Total Long-Term Assets
5.9M
+1.94%
5.8M
+11.06%
5.3M
+286.10%
1.4M
+185.71%
Total Assets
364.0M
-13.02%
418.5M
+17.82%
355.2M
+96.93%
180.4M
-31.52%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
0
-100.00%
10.5M
N/A
Total Current Liabilities
37.0M
-24.51%
49.0M
-22.47%
63.3M
+83.17%
34.5M
+45.98%
Total Long-Term Debt
N/A
N/A
N/A
N/A
29.3M
0.00%
29.3M
-19.83%
Total Long-Term Liabilities
87,000
-57.56%
205,000
-65.83%
600,000
0.00%
600,000
-74.49%
Total Liabilities
57.9M
-29.38%
82.0M
-7.76%
88.9M
+5.80%
84.0M
+6.32%
Retained Earnings
-1.1B
+26.57%
-873.0M
+17.63%
-742.1M
+10.55%
-671.4M
+17.97%
Total Stockholders Equity
306.1M
-9.03%
336.5M
+26.35%
266.3M
+176.36%
96.4M
-47.73%
Total Shares Outstanding
82.8M
+21.33%
68.3M
+39.20%
49.0M
+43.89%
34.1M
+0.52%
Cash Flow
Cash from Operating Activities
-240.1M
+90.22%
-126.2M
-6,832.05%
1.9M
+102.88%
-65.0M
+29.76%
Capital Expenditures
3.3M
-19.05%
4.1M
+16.34%
3.5M
+62.00%
2.1M
+1,278.21%
Cash from Investing Activities
68.6M
+131.26%
-219.4M
+6,517.04%
-3.3M
-80.80%
-17.3M
-47.87%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
173.6M
+5.87%
164.0M
-12.32%
187.1M
+27,211.59%
-690,000
-100.32%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-15,252.76%
+4,425.30%
-337.06%
+106.62%
-163.13%
-32.21%
-240.65%
+60.82%
Return on Assets
-59.29%
+75.25%
-33.83%
+27.96%
-26.44%
-42.64%
-46.09%
+40.08%
Return on Equity
-72.19%
+66.27%
-43.42%
+11.22%
-39.04%
-46.41%
-72.84%
+26.52%
Revenue Growth
-96.31%
+1,514.59%
-5.97%
-153.53%
11.14%
-7.81%
12.09%
+66.37%
Current Ratio
8.88
+13.59%
7.81
+43.38%
5.45
+8.93%
5.00
-50.21%
Cash Ratio
2.75
+35.29%
2.03
-54.28%
4.45
+60.56%
2.77
-63.32%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
0.11
-73.33%
0.41
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.08
-62.60%
0.22
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow